WUXI BIO (02269): Miao Jingwen appointed as non-executive director.
Wu Yibing, Ph.D., has resigned as of November 20, 2024, in an announcement from WuXi Biologics (02269).
WUXI BIO (02269) announces that, effective from November 20, 2024, Dr. Wu Yibing has resigned as a non-executive director and member of the Board's decision-making committee to dedicate more time to other personal matters. Ms. Miao Jingwen has been appointed as a non-executive director and member of the decision-making committee.
Related Articles
Full capacity production still unable to meet demand! Intel Corporation (INTC.US) CFO: The demand for server chips "continues to be strong" and supply bottlenecks will persist throughout the year.
"Ruyu" dividend release, BUTONG GROUP (06090) is expected to usher in a new round of bullish market.
From reasoning to training: Meta (META.US) announces the upgrade of its self-developed chip strategy, with the CFO calling customized chips the "core pillar."
Full capacity production still unable to meet demand! Intel Corporation (INTC.US) CFO: The demand for server chips "continues to be strong" and supply bottlenecks will persist throughout the year.
"Ruyu" dividend release, BUTONG GROUP (06090) is expected to usher in a new round of bullish market.
From reasoning to training: Meta (META.US) announces the upgrade of its self-developed chip strategy, with the CFO calling customized chips the "core pillar."
RECOMMEND
